Canada Opens Access for Psilocybin and MDMA Therapy
Cannabis Law Report
FEBRUARY 24, 2022
Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. 01.015 of the FDR before providing the new drug to a patient. Timeline of Medicinal Legalization in Canada. Pursuant to subsection C.08.010(1)
Let's personalize your content